Negative regulation of muscle hypertrophy

Across TCGA patient cohorts, RNA activity of the Negative regulation of muscle hypertrophy pathway is significantly associated with the RNA expression of multiple genes, with the UCEC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are FBN1, LINC00702, and AEBP1, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of muscle hypertrophy activity versus FBN1 in UCEC (Pearson r = 0.31).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	FBN1 →	+0.861	+0.185	<.001	<.001	3	7
CCRCC	LINC00702 →	+0.547	+0.212	.001	<.001	3	7
CCRCC	AEBP1 →	+1.396	+0.175	<.001	<.001	3	6
UCEC	ASPN →	+1.117	+0.144	<.001	.001	3	6
BRCA	LAMA4 →	+0.824	+0.236	<.001	<.001	3	6
BRCA	SPARC →	+1.139	+0.203	<.001	.006	3	6

Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0014741 vs FBN1 — UCEC

Explore this scatter interactively →